Theranicais a medical device company that integrates neuromodulation therapy with innovative wireless technology to create wearable solutions for various medical conditions and illnesses. These noninvasive therapeutic 'smart' patches are controlled via a smartphone app, offering personalized, portable, and cost-effective care. The patch features a proprietary 'smart' chip that generates electrical pulses to neuro-modulate the sensory nerves beneath the skin. Their initial application of this technology is focused on treating migraine headaches.
Theranica was founded in 2016 and operates in the Biotechnology and Health and Wellness industries. The company has recently attracted significant attention, securing a $45.00M Series C investment on 29 August 2022. The investors in this round include LionBird, Lightspeed Venture Partners, aMoon, New Rhein Healthcare Investors, Takoa Invest, and Corundum Open Innovations.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series C | $45.00M | 6 |
|
29 Aug 2022 |
| Series B | $35.00M | 4 |
|
18 Mar 2019 |
| Series A | $6.00M | - | 03 Jul 2017 | |
| Seed Round | Unknown | - | 21 Sep 2016 |
No recent news or press coverage available for Theranica.
We care about your data, and we'd love to use cookies make your experience better.
